The DOI matches its Crossref record; 9 of the 9 references it cites were found in a registry or an index.
Pharmacological characterization of the opioid inactive isomers (+)‐naltrexone and (+)‐naloxone as antagonists of toll‐like receptor 4
Open accessAbstract
Background and Purpose: The toll‐like receptor TLR4 is involved in neuropathic pain and in drug reward and reinforcement. The opioid inactive isomers (+)‐naltrexone and (+)‐naloxone act as TLR4 antagonists, reversing neuropathic pain and reducing opioid and cocaine reward and reinforcement. However, how these agents modulate TLR4 signalling is not clear. Here, we have elucidated the molecular mechanism of (+)‐naltrexone and (+)‐naloxone on TLR4 signalling. Experimental Approach: BV‐2 mouse microglial cell line, primary rat microglia and primary rat peritoneal macrophages were treated with LPS and TLR4 signalling inhibitors. Effects were measured using Western blotting, luciferase reporter assays, fluorescence microscopy and ELISA Key Results: (+)‐Naltrexone and (+)‐naloxone were equi‐potent inhibitors of the LPS‐induced TLR4 downstream signalling and induction of the pro‐inflammatory factors NO and TNF‐α. Similarly, (+)‐naltrexone or (+)‐naloxone inhibited production of reactive oxygen species and increased microglial phagocytosis, induced by LPS. However, (+)‐naltrexone and (+)‐naloxone did not directly inhibit the increased production of IL‐1β, induced by LPS. The drug interaction of (+)‐naloxone and (+)‐naltrexone was additive. (+)‐Naltrexone or (+)‐naloxone inhibited LPS‐induced activation of IFN regulatory factor 3 and production of IFN‐β. However, they did not inhibit TLR4 signalling via the activation of either NF‐κB, p38 or JNK in these cellular models. Conclusions and Implications: (+)‐Naltrexone and (+)‐naloxone were TRIF‐IFN regulatory factor 3 axis‐biased TLR4 antagonists. They blocked TLR4 downstream signalling leading to NO, TNF‐α and reactive oxygen species. This pattern may explain, at least in part, the in vivo therapeutic effects of (+)‐naltrexone and (+)‐naloxone.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Pattern Recognition Receptors and Inflammation
Takeuchi, O., & Akira, S. (2010) · Cell · doi:10.1016/j.cell.2010.01.022 · Cited by 8,895
Chou, T.-C. (2006) · Pharmacological Reviews · doi:10.1124/pr.58.3.10 · Cited by 5,163
Zhang, Y., Chen, K., Sloan, S. A., Bennett, M. L., Scholze, A. R., O'Keeffe, S., Phatnani, H. P., Guarnieri, P., Caneda, C., Ruderisch, N., et al. (2014) · The Journal of Neuroscience · doi:10.1523/jneurosci.1860-14.2014 · Cited by 4,875
Self-citationMicroglia-mediated neurotoxicity: uncovering the molecular mechanisms
Block, M. L., Zecca, L., & Hong, J.-S. (2007) · Nature Reviews Neuroscience · doi:10.1038/nrn2038 · Cited by 4,110
McGrath, J. C., & Lilley, E. (2015) · British Journal of Pharmacology · doi:10.1111/bph.12955 · Cited by 1,321
CD14 and Toll-Like Receptors 2 and 4 Are Required for Fibrillar Aβ-Stimulated Microglial Activation
Reed-Geaghan, E. G., Savage, J. C., Hise, A. G., & Landreth, G. E. (2009) · The Journal of Neuroscience · doi:10.1523/jneurosci.3158-09.2009 · Cited by 591
Theberge, F. R., Li, X., Kambhampati, S., Pickens, C. L., St. Laurent, R., Bossert, J. M., Baumann, M. H., Hutchinson, M. R., Rice, K. C., Watkins, L. R., et al. (2013) · Biological Psychiatry · doi:10.1016/j.biopsych.2012.12.019 · Cited by 119 · cited 1×
“Further, (+)-naltrexone and (+)-naloxone potentiated opioid-induced analgesia and decreased opioid-induced tolerance, hyperalgesia, conditioned place preference, self-administration and incubation of craving (Wu et al., 2006; Hutchinson et al., 2010; Hutchinson et al., 2012; Theberge et al., 2013; Northcutt et al., 20…”
BackgroundSelf-citationPhosphorylcholine mimics the effects of ES-62 on macrophages and dendritic cells
GOODRIDGE, H. S., McGUINESS, S., HOUSTON, K. M., EGAN, C. A., AL‐RIYAMI, L., ALCOCER, M. J. C., HARNETT, M. M., & HARNETT, W. (2007) · Parasite Immunology · doi:10.1111/j.1365-3024.2006.00926.x · Cited by 89 · cited 1×
“Additionally, the data presented here reinforce the warning that using the spontaneous TLR4 mutant CH3/HeJmouse strain as the only test of TLR4 involvement in biological systems is not adequate, given that this strain only lacks NF-kB signalling (Goodridge et al., 2007).”
BackgroundBrain microglia: watchdogs with pedigree
Neumann, H., & Wekerle, H. (2013) · Nature Neuroscience · doi:10.1038/nn.3338 · Cited by 34
Cited by
Neuroinflammation and Central Sensitization in Chronic and Widespread Pain
Ji, R.-R., Nackley, A., Huh, Y., Terrando, N., & Maixner, W. (2018) · Anesthesiology · doi:10.1097/aln.0000000000002130 · Cited by 1,630
Microglia in Pain: Detrimental and Protective Roles in Pathogenesis and Resolution of Pain
Chen, G., Zhang, Y.-Q., Qadri, Y. J., Serhan, C. N., & Ji, R.-R. (2018) · Neuron · doi:10.1016/j.neuron.2018.11.009 · Cited by 780
Self-citationThe role of neuroimmune signaling in alcoholism
Crews, F. T., Lawrimore, C. J., Walter, T. J., & Coleman, L. G. (2017) · Neuropharmacology · doi:10.1016/j.neuropharm.2017.01.031 · Cited by 321
Toll-like receptor 4 (TLR4) inhibitors: Current research and prospective
Zhang, Y., Liang, X., Bao, X., Xiao, W., & Chen, G. (2022) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2022.114291 · Cited by 299
Self-citationGlial and Neuroimmune Mechanisms as Critical Modulators of Drug Use and Abuse
Lacagnina, M. J., Rivera, P. D., & Bilbo, S. D. (2017) · Neuropsychopharmacology · doi:10.1038/npp.2016.121 · Cited by 271
“Likewise, (+)-naloxone and (+)-naltrexone, which are stereoisomers of traditional antagonists to opioid receptors, have been characterized as selective antagonists to TLR4 signaling with no appreciable function at opioid receptors (Hutchinson et al, 2011; Wang et al, 2016).”
Background
Metadata
- Authors
- Wang, X., Zhang, Y., Peng, Y., Hutchinson, M. R., Rice, K. C., Yin, H., & Watkins, L. R.
- Venue
- British Journal of Pharmacology
- Publisher
- Wiley
- Published
- 2016-02-04
- Volume
- 173
- Issue
- 5
- Pages
- 856-869
- ISSN
- 0007-1188 (ISSN-L)
- 1476-5381
- OpenAlex
- W2412243856
- Cited by
- 173
- References
- 9
- FWCI
- 5.77
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Pharmacological characterization of the opioid inactive isomers (+)‐naltrexone and (+)‐naloxone as antagonists of toll‐like receptor 4. https://app.cochat.ai/papers/10.1111/bph.13394
- The paper
- Wang, X., Zhang, Y., Peng, Y., Hutchinson, M. R., Rice, K. C., Yin, H., & Watkins, L. R. (2016). Pharmacological characterization of the opioid inactive isomers (+)‐naltrexone and (+)‐naloxone as antagonists of toll‐like receptor 4. British Journal of Pharmacology. https://doi.org/10.1111/bph.13394
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.